Photronics (PLAB) director exercises 5,000 options and sells 5,000 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Photronics Inc director Lee Kang Jyh exercised stock options for 5,000 shares of common stock at $10.75 per share and on the same day sold 5,000 shares at $40.80 per share in an open-market transaction. Following these transactions, he directly holds 385,850 common shares. The exercised options were part of a grant that vested in four equal annual installments beginning on March 7, 2017, and the options were scheduled to expire on March 7, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 5,000 shares ($204,000)
Net Sell
3 txns
Insider
Lee Kang Jyh
Role
Director
Sold
5,000 shs ($204K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | PHOTRONICS STOCK OPTIONS | 5,000 | $0.00 | -- |
| Exercise | COMMON STOCK | 5,000 | $10.75 | $54K |
| Sale | COMMON STOCK | 5,000 | $40.80 | $204K |
Holdings After Transaction:
PHOTRONICS STOCK OPTIONS — 5,000 shares (Direct);
COMMON STOCK — 390,850 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Options exercised: 5,000 options
Shares sold: 5,000 shares
Post-transaction holdings: 385,850 shares
+3 more
6 metrics
Options exercised
5,000 options
Exercised on March 26, 2026 at $10.75 per share
Shares sold
5,000 shares
Open-market sale on March 26, 2026 at $40.80 per share
Post-transaction holdings
385,850 shares
Common stock directly owned after March 26, 2026 sale
Option exercise price
$10.75 per share
Exercise price for PHOTRONICS STOCK OPTIONS grant
Option expiration date
March 7, 2027
Expiration for the exercised stock options
Vesting schedule
25% annually over 4 years
Options vested each year from March 7, 2017 grant date
Key Terms
Exercise or conversion of derivative security, open-market sale, PHOTRONICS STOCK OPTIONS, Common Stock
4 terms
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
PHOTRONICS STOCK OPTIONS financial
"security_title: PHOTRONICS STOCK OPTIONS"
Common Stock financial
"underlying_security_title: PHOTRONICS INC Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did Photronics (PLAB) director Lee Kang Jyh report?
Director Lee Kang Jyh reported exercising stock options for 5,000 Photronics common shares at $10.75 per share and then selling 5,000 common shares at $40.80 per share. These same-day transactions combined a derivative exercise with an open-market sale.
What were the exercise and sale prices in the Photronics (PLAB) director’s Form 4?
The director exercised 5,000 stock options at an exercise price of $10.75 per share and sold 5,000 common shares at $40.80 per share. These prices show the terms of the option grant and the subsequent open-market sale on that transaction date.
What type of transactions are shown in this Photronics (PLAB) Form 4 filing?
The filing shows a derivative exercise and an open-market sale. First, 5,000 stock options were exercised into 5,000 shares of common stock, then 5,000 common shares were sold in an open-market or private transaction coded as an “S” sale.
When did the Photronics (PLAB) stock options exercised by the director originally vest and expire?
The reported options vested in four equal annual installments, with 25% vesting on each anniversary of the March 7, 2017 grant date. According to the filing, the options carried an expiration date of March 7, 2027 if not previously exercised.